Literature DB >> 10740133

Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure.

M Packer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740133     DOI: 10.1016/s0002-8703(00)90074-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  4 in total

1.  Rethinking Phase II Clinical Trial Design in Heart Failure.

Authors:  Kory J Lavine; Douglas L Mann
Journal:  Clin Investig (Lond)       Date:  2013-01-01

Review 2.  Phase II trials in heart failure: the role of cardiovascular imaging.

Authors:  Sanjiv J Shah; Gregg C Fonarow; Mihai Gheorghiade; Roberto M Lang
Journal:  Am Heart J       Date:  2011-07       Impact factor: 4.749

3.  Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.

Authors:  Catherine N Marti; Gregg C Fonarow; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

Review 4.  Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Authors:  Pupalan Iyngkaran; Danny Liew; Peter McDonald; Merlin C Thomas; Christopher Reid; Derek Chew; David L Hare
Journal:  Curr Cardiol Rev       Date:  2016
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.